Compare DOO & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOO | IRTC |
|---|---|---|
| Founded | 1937 | 2006 |
| Country | Canada | United States |
| Employees | N/A | 2400 |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2018 | 2016 |
| Metric | DOO | IRTC |
|---|---|---|
| Price | $57.78 | $109.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $85.67 | ★ $197.92 |
| AVG Volume (30 Days) | 261.5K | ★ 464.4K |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $747,138,000.00 |
| Revenue This Year | $8.48 | $19.60 |
| Revenue Next Year | $5.10 | $15.94 |
| P/E Ratio | $338.95 | ★ N/A |
| Revenue Growth | N/A | ★ 26.24 |
| 52 Week Low | $48.83 | $100.85 |
| 52 Week High | $81.89 | $210.01 |
| Indicator | DOO | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 39.27 | 37.78 |
| Support Level | $52.66 | $102.62 |
| Resistance Level | $63.73 | $127.33 |
| Average True Range (ATR) | 2.41 | 4.62 |
| MACD | -0.57 | -1.21 |
| Stochastic Oscillator | 1.98 | 10.36 |
BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which has largely been divested; Manitou was sold in the third quarter of fiscal 2026, and Telwater remains up for sale. At the end of fiscal 2026, the company sold its products through a network of more than 2,050 independent dealers and 140 distributors in around 110 countries.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.